Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Silencing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Transcriptional
1.2.3 Post-transcriptional
1.2.4 Meiotic
1.3 Market by Application
1.3.1 Global Gene Silencing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer Treatment
1.3.3 Neurological Diseases Treatment
1.3.4 Scar Treatment
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Silencing Market Perspective (2018-2033)
2.2 Gene Silencing Growth Trends by Region
2.2.1 Global Gene Silencing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gene Silencing Historic Market Size by Region (2018-2023)
2.2.3 Gene Silencing Forecasted Market Size by Region (2024-2033)
2.3 Gene Silencing Market Dynamics
2.3.1 Gene Silencing Industry Trends
2.3.2 Gene Silencing Market Drivers
2.3.3 Gene Silencing Market Challenges
2.3.4 Gene Silencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Silencing Players by Revenue
3.1.1 Global Top Gene Silencing Players by Revenue (2018-2023)
3.1.2 Global Gene Silencing Revenue Market Share by Players (2018-2023)
3.2 Global Gene Silencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Silencing Revenue
3.4 Global Gene Silencing Market Concentration Ratio
3.4.1 Global Gene Silencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Silencing Revenue in 2022
3.5 Gene Silencing Key Players Head office and Area Served
3.6 Key Players Gene Silencing Product Solution and Service
3.7 Date of Enter into Gene Silencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Silencing Breakdown Data by Type
4.1 Global Gene Silencing Historic Market Size by Type (2018-2023)
4.2 Global Gene Silencing Forecasted Market Size by Type (2024-2033)
5 Gene Silencing Breakdown Data by Application
5.1 Global Gene Silencing Historic Market Size by Application (2018-2023)
5.2 Global Gene Silencing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gene Silencing Market Size (2018-2033)
6.2 North America Gene Silencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Gene Silencing Market Size by Country (2018-2023)
6.4 North America Gene Silencing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Silencing Market Size (2018-2033)
7.2 Europe Gene Silencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Gene Silencing Market Size by Country (2018-2023)
7.4 Europe Gene Silencing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Silencing Market Size (2018-2033)
8.2 Asia-Pacific Gene Silencing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Gene Silencing Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Silencing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Silencing Market Size (2018-2033)
9.2 Latin America Gene Silencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Gene Silencing Market Size by Country (2018-2023)
9.4 Latin America Gene Silencing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Silencing Market Size (2018-2033)
10.2 Middle East & Africa Gene Silencing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Gene Silencing Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Silencing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Gene Silencing Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2018-2023)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Benitec Biopharma
11.2.1 Benitec Biopharma Company Detail
11.2.2 Benitec Biopharma Business Overview
11.2.3 Benitec Biopharma Gene Silencing Introduction
11.2.4 Benitec Biopharma Revenue in Gene Silencing Business (2018-2023)
11.2.5 Benitec Biopharma Recent Development
11.3 Arrowhead Pharmaceuticals
11.3.1 Arrowhead Pharmaceuticals Company Detail
11.3.2 Arrowhead Pharmaceuticals Business Overview
11.3.3 Arrowhead Pharmaceuticals Gene Silencing Introduction
11.3.4 Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2018-2023)
11.3.5 Arrowhead Pharmaceuticals Recent Development
11.4 Merck Group
11.4.1 Merck Group Company Detail
11.4.2 Merck Group Business Overview
11.4.3 Merck Group Gene Silencing Introduction
11.4.4 Merck Group Revenue in Gene Silencing Business (2018-2023)
11.4.5 Merck Group Recent Development
11.5 Eli Lilly (Dicerna Pharmaceuticals)
11.5.1 Eli Lilly (Dicerna Pharmaceuticals) Company Detail
11.5.2 Eli Lilly (Dicerna Pharmaceuticals) Business Overview
11.5.3 Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Introduction
11.5.4 Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2018-2023)
11.5.5 Eli Lilly (Dicerna Pharmaceuticals) Recent Development
11.6 Monsanto (Bayer AG)
11.6.1 Monsanto (Bayer AG) Company Detail
11.6.2 Monsanto (Bayer AG) Business Overview
11.6.3 Monsanto (Bayer AG) Gene Silencing Introduction
11.6.4 Monsanto (Bayer AG) Revenue in Gene Silencing Business (2018-2023)
11.6.5 Monsanto (Bayer AG) Recent Development
11.7 RXi Pharmaceuticals
11.7.1 RXi Pharmaceuticals Company Detail
11.7.2 RXi Pharmaceuticals Business Overview
11.7.3 RXi Pharmaceuticals Gene Silencing Introduction
11.7.4 RXi Pharmaceuticals Revenue in Gene Silencing Business (2018-2023)
11.7.5 RXi Pharmaceuticals Recent Development
11.8 Silence Therapeutics plc
11.8.1 Silence Therapeutics plc Company Detail
11.8.2 Silence Therapeutics plc Business Overview
11.8.3 Silence Therapeutics plc Gene Silencing Introduction
11.8.4 Silence Therapeutics plc Revenue in Gene Silencing Business (2018-2023)
11.8.5 Silence Therapeutics plc Recent Development
11.9 Idera Pharmaceuticals
11.9.1 Idera Pharmaceuticals Company Detail
11.9.2 Idera Pharmaceuticals Business Overview
11.9.3 Idera Pharmaceuticals Gene Silencing Introduction
11.9.4 Idera Pharmaceuticals Revenue in Gene Silencing Business (2018-2023)
11.9.5 Idera Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Silencing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Transcriptional
Table 3. Key Players of Post-transcriptional
Table 4. Key Players of Meiotic
Table 5. Global Gene Silencing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Gene Silencing Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gene Silencing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Gene Silencing Market Share by Region (2018-2023)
Table 9. Global Gene Silencing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Gene Silencing Market Share by Region (2024-2033)
Table 11. Gene Silencing Market Trends
Table 12. Gene Silencing Market Drivers
Table 13. Gene Silencing Market Challenges
Table 14. Gene Silencing Market Restraints
Table 15. Global Gene Silencing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Gene Silencing Market Share by Players (2018-2023)
Table 17. Global Top Gene Silencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Silencing as of 2022)
Table 18. Ranking of Global Top Gene Silencing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Gene Silencing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Silencing Product Solution and Service
Table 22. Date of Enter into Gene Silencing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Silencing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Gene Silencing Revenue Market Share by Type (2018-2023)
Table 26. Global Gene Silencing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Gene Silencing Revenue Market Share by Type (2024-2033)
Table 28. Global Gene Silencing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Gene Silencing Revenue Market Share by Application (2018-2023)
Table 30. Global Gene Silencing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Gene Silencing Revenue Market Share by Application (2024-2033)
Table 32. North America Gene Silencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Gene Silencing Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Gene Silencing Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Gene Silencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Gene Silencing Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Gene Silencing Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Gene Silencing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Gene Silencing Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Gene Silencing Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Gene Silencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Gene Silencing Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Gene Silencing Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Gene Silencing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Gene Silencing Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Gene Silencing Market Size by Country (2024-2033) & (US$ Million)
Table 47. Alnylam Pharmaceuticals Company Detail
Table 48. Alnylam Pharmaceuticals Business Overview
Table 49. Alnylam Pharmaceuticals Gene Silencing Product
Table 50. Alnylam Pharmaceuticals Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 51. Alnylam Pharmaceuticals Recent Development
Table 52. Benitec Biopharma Company Detail
Table 53. Benitec Biopharma Business Overview
Table 54. Benitec Biopharma Gene Silencing Product
Table 55. Benitec Biopharma Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 56. Benitec Biopharma Recent Development
Table 57. Arrowhead Pharmaceuticals Company Detail
Table 58. Arrowhead Pharmaceuticals Business Overview
Table 59. Arrowhead Pharmaceuticals Gene Silencing Product
Table 60. Arrowhead Pharmaceuticals Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 61. Arrowhead Pharmaceuticals Recent Development
Table 62. Merck Group Company Detail
Table 63. Merck Group Business Overview
Table 64. Merck Group Gene Silencing Product
Table 65. Merck Group Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 66. Merck Group Recent Development
Table 67. Eli Lilly (Dicerna Pharmaceuticals) Company Detail
Table 68. Eli Lilly (Dicerna Pharmaceuticals) Business Overview
Table 69. Eli Lilly (Dicerna Pharmaceuticals) Gene Silencing Product
Table 70. Eli Lilly (Dicerna Pharmaceuticals) Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 71. Eli Lilly (Dicerna Pharmaceuticals) Recent Development
Table 72. Monsanto (Bayer AG) Company Detail
Table 73. Monsanto (Bayer AG) Business Overview
Table 74. Monsanto (Bayer AG) Gene Silencing Product
Table 75. Monsanto (Bayer AG) Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 76. Monsanto (Bayer AG) Recent Development
Table 77. RXi Pharmaceuticals Company Detail
Table 78. RXi Pharmaceuticals Business Overview
Table 79. RXi Pharmaceuticals Gene Silencing Product
Table 80. RXi Pharmaceuticals Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 81. RXi Pharmaceuticals Recent Development
Table 82. Silence Therapeutics plc Company Detail
Table 83. Silence Therapeutics plc Business Overview
Table 84. Silence Therapeutics plc Gene Silencing Product
Table 85. Silence Therapeutics plc Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 86. Silence Therapeutics plc Recent Development
Table 87. Idera Pharmaceuticals Company Detail
Table 88. Idera Pharmaceuticals Business Overview
Table 89. Idera Pharmaceuticals Gene Silencing Product
Table 90. Idera Pharmaceuticals Revenue in Gene Silencing Business (2018-2023) & (US$ Million)
Table 91. Idera Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Silencing Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Gene Silencing Market Share by Type: 2022 VS 2033
Figure 3. Transcriptional Features
Figure 4. Post-transcriptional Features
Figure 5. Meiotic Features
Figure 6. Global Gene Silencing Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Gene Silencing Market Share by Application: 2022 VS 2033
Figure 8. Cancer Treatment Case Studies
Figure 9. Neurological Diseases Treatment Case Studies
Figure 10. Scar Treatment Case Studies
Figure 11. Other Case Studies
Figure 12. Gene Silencing Report Years Considered
Figure 13. Global Gene Silencing Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Gene Silencing Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Gene Silencing Market Share by Region: 2022 VS 2033
Figure 16. Global Gene Silencing Market Share by Players in 2022
Figure 17. Global Top Gene Silencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Silencing as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gene Silencing Revenue in 2022
Figure 19. North America Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Gene Silencing Market Share by Country (2018-2033)
Figure 21. United States Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Gene Silencing Market Share by Country (2018-2033)
Figure 25. Germany Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Gene Silencing Market Share by Region (2018-2033)
Figure 33. China Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Gene Silencing Market Share by Country (2018-2033)
Figure 41. Mexico Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Gene Silencing Market Share by Country (2018-2033)
Figure 45. Turkey Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Gene Silencing Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 48. Benitec Biopharma Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 49. Arrowhead Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 50. Merck Group Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 51. Eli Lilly (Dicerna Pharmaceuticals) Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 52. Monsanto (Bayer AG) Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 53. RXi Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 54. Silence Therapeutics plc Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 55. Idera Pharmaceuticals Revenue Growth Rate in Gene Silencing Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed